Therefore, we evaluated the treatment with RVT-FxMe on functional alterations of erectile function in two murine models that display low NO-cGMP bioavailability and elevated oxidative stress, SCD and eNOS-/- mice. The gene discussed is NOS3; the disease is Schnyder corneal dystrophy.